Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection

Vaccine

Volumn 32, Issue 30, 2014, Pages 3835-3842

  Pyo, Hyun Mi ^a   Zhou, Yan ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Live attenuated vaccine; Swine influenza virus

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; SIV 606 VACCINE; SWINE INFLUENZA VACCINE; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; INFLUENZA VACCINE; LIVE VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BRONCHUS; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LUNG LESION; LUNG PARENCHYMA; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; SWINE INFLUENZA; TRACHEA; TREATMENT RESPONSE; VIRUS IMMUNITY; VIRUS LOAD; VIRUS NEUTRALIZATION; ANIMAL; BLOOD; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; ORTHOMYXOVIRIDAE INFECTIONS; PIG; RANDOMIZATION; SERODIAGNOSIS; SWINE DISEASES; VETERINARY; VIROLOGY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INTERFERON-GAMMA; LUNG; LYMPH NODES; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; RANDOM ALLOCATION; SWINE; SWINE DISEASES; VACCINES, ATTENUATED;

EID: 84922223667     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.065     Document Type: Article

References (33)

1. Crisci E., Mussa T., Fraile L., Montoya M. Review: influenza virus in pigs. Mol Immunol 2013, 55(3-4):200-211.
2. Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet Res 2007, 38(2):243-260.
3. Ma W., Lager K.M., Vincent A.L., Janke B.H., Gramer M.R., Richt J.A. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 2009, 56(August (6-7)):326-337.
4. Cohen J. Pandemic influenza. Straight from the pig's mouth: swine research with swine influenzas. Science 2009, 325(July (5937)):140-141.
5. Swine-origin influenza A (H3N2) virus infection in two children-Indiana and Pennsylvania, July-August. MMWR Morb Mortal Wkly Rep 2011, 60(September 9 (35)):1213-1215.
6. CDC H1N2 variant virus detected in Minnesota 2012, Available from: http://www.cdc.gov/flu/spotlights/h1n2v-cases-mn.htm [cited 02.12.13].
7. CDC Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count-United States, 2012. MMWR Morb Mortal Wkly Rep 2012, 61(August (32)):619-621.
8. Kitikoon P., Vincent A.L., Gauger P.C., Schlink S.N., Bayles D.O., Gramer M.R., et al. Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol 2012, 86(June12):6804-6814.
9. Ali A., Khatri M., Wang L., Saif Y.M., Lee C.W. Identification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs, United States. Vet Microbiol 2012, 158(July (1-2)):60-68.
10. Skowronski D.M., Janjua N.Z., De Serres G., Purych D., Gilca V., Scheifele D.W., et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis 2012, 206(December (12)):1852-1861.
11. Houser K.V., Katz J.M., Tumpey T.M. Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J Virol 2013, 87(January (2)):1261-1263.
12. Osterholm M.T. Preparing for the next pandemic. N Engl J Med 2005, 352(May (18)):1839-1842.
13. Van Reeth K., Ma W. Swine influenza virus vaccines: to change or not to change-that's the question. Curr Top Microbiol Immunol 2013, 370:173-200.
14. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004, 59(January (1)):1-15.
15. Vincent A.L., Ciacci-Zanella J.R., Lorusso A., Gauger P.C., Zanella E.L., Kehrli M.E., et al. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010, 28(March (15)):2782-2787.
16. Cheng X., Zengel J.R., Suguitan A.L., Xu Q., Wang W., Lin J., et al. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J Infect Dis 2013, 208(August (4)):594-602.
17. Loving C.L., Vincent A.L., Pena L., Perez D.R. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs. Vaccine 2012, 30(August (40)):5830-5838.
18. Vincent A.L., Ma W., Lager K.M., Richt J.A., Janke B.H., Sandbulte M.R., et al. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J Virol 2012, 86(October (19)):10597-10605.
19. Masic A., Pyo H.M., Babiuk S., Zhou Y. An eight-segment swine influenza virus harbouring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs. J Virol 2013, 87:10114-10125.
20. Masic A., Babiuk L.A., Zhou Y. Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs. J Gen Virol 2009, 90(February (Pt. 2)):375-385.
21. Webby R.J., Rossow K., Erickson G., Sims Y., Webster R. Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Virus Res 2004, 103(July (1-2)):67-73.
22. Shin Y.K., Liu Q., Tikoo S.K., Babiuk L.A., Zhou Y. Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 2007, 88(January (Pt. 1)):13-18.
23. Masic A., Booth J.S., Mutwiri G.K., Babiuk L.A., Zhou Y. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. J Virol 2009, 83(October (19)):10198-10210.
24. WHO Manual on Animal Influenza Diagnosis and Surveillance 2002, World Health Organization, Geneva. 2nd ed. R. Webster, N. Cox, K. Stöhr (Eds.).
25. Reed L.J., Muench H. A simple method of estimating fifty percent endpoint. Am J Hyg 1938, 27:5.
26. Mitnaul L.J., Castrucci M.R., Murti K.G., Kawaoka Y. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J Virol 1996, 70(February (2)):873-879.
27. Gizurarson S. Anatomical and histological factors affecting intranasal drug and vaccine delivery. Curr Drug Deliv 2012, 9(November (6)):566-582.
28. Zaman M., Chandrudu S., Toth I. Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res 2013, 3(February (1)):100-109.
29. Bodewes R., Kreijtz J.H., van Amerongen G., Hillaire M.L., Vogelzang-van Trierum S.E., Nieuwkoop N.J., et al. Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal inoculation. J Virol 2013, 87:4293-4301.
30. Pena L., Sutton T., Chockalingam A., Kumar S., Angel M., Shao H., et al. Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol 2013, 87(May (9)):5118-5127.
31. Uraki R., Kiso M., Iwatsuki-Horimoto K., Fukuyama S., Takashita E., Ozawa M., et al. A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges. J Virol 2013, 87(July (14)):7874-7881.
32. Gao Q., Lowen A.C., Wang T.T., Palese P. A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins. J Virol 2010, 84(August (16)):8062-8071.
33. Bandell A., Woo J., Coelingh K. Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference. Expert Rev Vaccines 2011, 10(August (8)):1131-1141.